IP Library Granted Patent US 12,209,277
Granted Patent B2
US 12,209,277 · App. 16/260,475 · Granted Jan 28, 2025

Methods and compositions for deconvoluting partition barcodes

Inventors: Sean Cater (Pinole, CA); Lucas Frenz (San Leandro, CA); Andrew Kohlway (Pleasanton, CA); Jennifer Chew (Sunnyvale, CA); Rob Ray (Oakland, CA); Ronald Lebofsky (Kensington, CA)
Assignee: Bio-Rad Laboratories, Inc.
C12Q1/6853C12N15/1065C12Q1/6806
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,209,277
App. No.
16/260,475
Granted
Jan 28, 2025
Kind
B2
Abstract

Methods are provided of assessing whether multiple differently-barcoded primers occur within the same partition.

Claims (30)

1. A method of detecting the presence or absence of multiple barcodes in a partition, the method comprising,

forming partitions comprising

forward primers comprising a barcode and a capture sequence complementary to a 3′ sequence, or reverse complement thereof, of a sample target nucleic acid, wherein different partitions contain different forward primers comprising different barcode sequences unique to the partitions where the barcodes reside compared to barcodes present in other partitions and wherein in at least one partition the forward primers comprise copies of first and second forward primers comprising different barcode sequences,

the sample target nucleic acid,

multiple copies of a partition ID tag oligonucleotide having a combination of sequences unique to the partition in which the partition ID tag oligonucleotide resides and_comprising a 3′ end sequence that comprises a reverse complement of the capture sequence and a 5′ sequence comprising a variable partition ID tag sequence, wherein the partition ID tag oligonucleotide is a DNA oligonucleotide;

in the partitions, hybridizing the capture sequence of at least some copies of the first and the second forward primers to different copies of the partition ID tag oligonucleotide to form hybridized products, and

hybridizing the capture sequence of other copies of the first and the second forward primers to the sample target nucleic acid;

performing polymerase chain reaction amplification on the hybridized products to form amplicons, wherein at least some amplicons are formed from a first forward primer and the partition ID tag oligonucleotide and at least some amplicons are formed from a second forward primer and the partition ID tag oligonucleotide; and

sequencing the amplicons, wherein if different forward primers form amplicons with the same variable partition ID tag sequence in a partition, the different forward primers are from the same partition, wherein

the partition ID tag oligonucleotide comprises a double-stranded variable partition ID tag sequence and one or two single-stranded 3′ ends comprising the reverse complement of the capture sequence.

2. The method of claim 1 , wherein the forward primers, the partition ID tag oligonucleotide, or both further comprise a universal adaptor sequence.

3. The method of claim 1 , wherein the performing also amplifies the sample target nucleic acid with the forward primers and sample target reverse primers to form an amplification product and the sequencing comprises sequencing the amplification products.

4. The method of claim 1 , wherein in the partition forming step the forward primers are linked to a bead.

5. The method of claim 4 , wherein the forward primers are cleaved from the bead before the amplifying.

6. The method of claim 1 , wherein multiple copies of partition ID tag oligonucleotides are linked to each other.

7. The method of claim 6 , wherein the multiple copies are linked to each other through a bead.

8. The method of claim 7 , wherein the bead is linked to forward primers and partition ID tag oligonucleotides and the bead comprises at least 10 times the number of the forward primers compared to the partition ID tag oligonucleotides linked to the bead.

9. The method of claim 6 , wherein during partition forming the forward primers and the partition ID tag oligonucleotides are linked to each other via a cleavable linker and the method further comprises cleaving the cleavable linker before the amplification.

10. The method of claim 1 , wherein the partition ID tag oligonucleotide is single-stranded.

11. The method of claim 1 , wherein the variable partition ID tag sequence is double-stranded and comprises two single-stranded 3′ ends comprising the reverse complement of the capture sequence.

12. The method of claim 1 , wherein during the partition forming step the partition ID tag oligonucleotide is linked to a solid support.

13. The method of claim 1 , wherein the partition ID tag oligonucleotide comprises an affinity tag.

14. The method of claim 13 , wherein the affinity tag is biotin, an antibody, or an aptamer.

15. The method of claim 1 , wherein the partitions are droplets.

16. The method of claim 1 , wherein contents of the partitions comprising the hybridized product are combined before the amplifying.

17. The method of claim 1 , wherein sample target reverse primers are present in the partitions.

18. The method of claim 1 , wherein sample target reverse primers are introduced after contents of the partitions are combined.

19. The method of claim 1 , wherein the amplification occurs while the hybridized products are within the partitions.

20. The method of claim 1 , wherein the partition ID tag oligonucleotide is 4-50 nucleotides in length.

21. The method of claim 1 , wherein the variable partition ID tag sequence is double-stranded and comprises only one single-stranded 3′ end comprising the reverse complement of the capture sequence.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2019
From: CATER, SEAN; FRENZ, LUCAS; RAY, ROB; LEBOFSKY, RONALD; CHEW, JENNIFER; KOHLWAY, ANDREW
To: BIO-RAD LABORATORIES, INC.
Reel/Frame 050505/0089 →
Continuity (2)
Provisional Application 62624400 · Jan 31, 2018
Related Publication 20190241944A1 · Aug 8, 2019
References Cited (19)
US 10730030B2 · Lebofsky et al. · 2020 [cited by examiner]
US 20060281079A1 · Eickbush et al. · 2006 [cited by applicant]
US 20090035777A1 · Kokoris et al. · 2009 [cited by examiner]
US 20120034603A1 · Oliphant et al. · 2012 [cited by applicant]
US 20160312276A1 · Fu et al. · 2016 [cited by applicant]
US 20170232417A1 · Lebofsky et al. · 2017 [cited by applicant]
US 20200324264A1 · Lebofsky et al. · 2020 [cited by applicant]
WO WO2011056866A2 · 2011 [cited by examiner]
WO WO2014144495A1 · 2014 [cited by examiner]
WO 2015200541A1 · 2015 [cited by applicant]
WO 2017079593A1 · 2017 [cited by applicant]
WO 2017120531A1 · 2017 [cited by applicant]
WO 2018017914A1 · 2018 [cited by applicant]
Gerard et al. “Reverse Transcriptase (EC 2.7.7.49)” Chapter 6 (73-93) From: Methods in Molecular Biology, vol. 16: Enzymes of Molecular Biology Edited by: M. M. Burell 1993 Humana Press Inc. Totowa, NJ (Year: 1993). [cited by examiner]
Parameswaran et al. “A pyrosequencing-tailored nucleotide barcode design unveils opportunities for large-scale sample multiplexing”, Nucleic acid research, vol. 35, No. 19, published Oct. 11, 2007 (Year: 2007). [cited by examiner]
International Search Report and Written Opinion in PCT/US2019/015638 mailed Jul. 5, 2019; 15 pages. [cited by applicant]
Lan, F. et al.; “Droplet barcoding for massively parallel single-molecule deep sequencing”; [cited by applicant]
Extended European Search Report from EP 19747263.2 mailed Sep. 28, 2021; 7 pages. [cited by applicant]
Griebel, T. et al.; “Modelling and simulating generic RNA-Seq experiments with the flux simulator”; [cited by applicant]